Application 020695

Type
NDA
Sponsor
OTSUKA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RAXARGREPAFLOXACIN HYDROCHLORIDETABLET;ORALEQ 200MG BASENoNo
002RAXARGREPAFLOXACIN HYDROCHLORIDETABLET;ORALEQ 400MG BASENoNo
003RAXARGREPAFLOXACIN HYDROCHLORIDETABLET;ORALEQ 600MG BASENoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020695-001RAXARGREPAFLOXACIN HYDROCHLORIDEEQ 200MG BASETABLET / ORAL1997-11-06
N020695-002RAXARGREPAFLOXACIN HYDROCHLORIDEEQ 400MG BASETABLET / ORAL1998-05-14
N020695-003RAXARGREPAFLOXACIN HYDROCHLORIDEEQ 600MG BASETABLET / ORAL1998-05-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N020695-001RAXAREQ 200MG BASETABLET / ORAL1997-11-06a50c72e98297…
2026-08-01 22:54:322026-06N020695-002RAXAREQ 400MG BASETABLET / ORAL1998-05-14a50c72e98297…
2026-08-01 22:54:322026-06N020695-003RAXAREQ 600MG BASETABLET / ORAL1998-05-14a50c72e98297…

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
41560ORIG2004-07-15
41561SUPPL2004-06-28